Votre inscription
Compte en attente de validation.
Votre compte est en cours de validation. Nous vous enverrons un email de confirmation dans les jours à venir.
Cliquez 
59
TREATABLE TRAITS: FROM DISCUSSION TO ACTION
Chair: Prof. Neil Barnes
Global Specialty & Primary Care, GSK, London, UK
Chair: Dr Dave Leather
Global Specialty & Primary Care, GSK, London, UK
Speaker: Prof. Alvar Agusti
Respiratory Institute, Hospital Clinic, Universitat de Barcelona and Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Speaker: Prof. Ian Pavord
Nuffield Department of Medicine and Oxford Respitory NIHR BRC, University of Oxford, Oxford, UK
Speaker: Prof. Vanessa McDonald
The University of Newcastle, Callaghan, New South Wales, Australia
The symposium will introduce and explore the concept of treating traits in respiratory disease using data from recent clinical trials. We will also discuss how this approach can be applied to clinical practice. Following the presentations there will be a live interactive session where our expert speakers will be available to answer your questions.
PRECISION MEDICINE IN EOSINOPHILIC INFLAMATION
Chair: Prof. Peter Howarth
Global Respiratory, GSK, London, UK
Prof. Arnaud Bourdin
Hôpital Arnaud de Villeneuve, University of Montpellier, Montpellier, France
Prof. Ian Pavord
Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Dr. David Jackson
Guy’s Severe Asthma Centre, Guy’s & St Thomas’ Hospitals, King’s College London, London, UK
Dr. Neil Martin
Global Medical Affairs, GSK, UK
In this symposium we will discuss what it means to treat severe eosinophilic asthma through precision medicine, key clinical data, and how, when and why to select a precision medicine approach. Following the presentations, there will be a live interactive session where our expert speakers will be available to answer your questions.
NEW CLINICAL AND REAL-WORD DATA TO INFORM TREATMENT CHOICES IN COPD: LOOKING FROM A PATIENT PERSPECTIVE
Chair and speaker: Prof. Paul Jones
Global Specialty & Primary Care, GSK, London, UK
Speaker: Prof. David Halpin
Department of Respiratory Medicine, Royal Devon and Exeter Hospital, Exeter, UK
Speaker: Prof. François Maltais
Centre de Pneumologie, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Canada
The symposium will focus on what is important in COPD treatment from the patient perspective. We will discuss the measurement of symptoms, informed by patients in both real life and clinical trials. Following the presentations, there will be a live interactive session where our expert speakers will be available to answer your questions.
COPD TREATMENT: WHAT IS THE MOST IMPORTANT TARGET?
Chair: Prof. Neil Barnes
Global Specialty & Primary Care, GSK, London, UK
Speaker: Prof. Claus Vogelmeier
Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Glessen and Marburg Philipps-Universität Marburg, Germany, Member of the German Center for Lung Research (DZL), Germany
Speaker: Prof. Alice Turner
University Hospitals Birmingham NHS Foundation Trust, and Institute of Applied Health Research, University of Birmingham, UK
Speaker: Prof. MeiLan Han
Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA
Speaker: Prof. Alberto Papi
Respiratory Medicine Unit, Department of Medical Sciences, Università di Ferrara, Ferrara, Italy
In this symposium we will discuss what should be the target of COPD treatment; is it reducing symptoms, preventing exacerbations or increasing patient survival? Following the presentation, there will be a live interactive session where our expert speakers will be available to answer your questions.
RELEVANT ENDPOINTS IN ASTHMA PATIENTS (REAP)
Speaker: Prof. Alberto Papi
Respiratory Medicine Unit, Department of Medical Sciences, Università di Ferrara, Ferrara, Italy
Speaker: Prof. Ashley Woodcock
Division of Infection, Immunity and Respiratory Medicine, University of Manchester and university Hospital of South Manchester NHS Foundation Trust, Manchester, UK
Speaker: Prof. Ken Chapman
Asthma and Airway Center, University Health Network, University of Toronto, Toronto, Ontario, Canada
The symposium will focus on the importance of selecting relevant endpoints for the treatment of patients with asthma. We will discuss the relevance of these endpoints to patients’ lives, informed by data from both real life and clinical trials. Following the presentations, there will be a live interactive session where our expert speakers will be available to answer your questions.
